HK1133991A1 - Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice - Google Patents

Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice

Info

Publication number
HK1133991A1
HK1133991A1 HK10102016.4A HK10102016A HK1133991A1 HK 1133991 A1 HK1133991 A1 HK 1133991A1 HK 10102016 A HK10102016 A HK 10102016A HK 1133991 A1 HK1133991 A1 HK 1133991A1
Authority
HK
Hong Kong
Prior art keywords
avermectin
lice
elimination
susceptible
resistant strains
Prior art date
Application number
HK10102016.4A
Other languages
English (en)
Chinese (zh)
Inventor
Nicholas Spring
Garry T Gwozdz
Original Assignee
Topaz Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39468571&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1133991(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Topaz Pharmaceuticals Inc filed Critical Topaz Pharmaceuticals Inc
Publication of HK1133991A1 publication Critical patent/HK1133991A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK10102016.4A 2006-10-12 2010-02-25 Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice HK1133991A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85135206P 2006-10-12 2006-10-12
US97625907P 2007-09-28 2007-09-28
PCT/US2007/081258 WO2008067054A2 (fr) 2006-10-12 2007-10-12 Formulations topiques d'avermectine et procédés d'élimination et de prophylaxie de souches de poux susceptibles et résistantes au traitement

Publications (1)

Publication Number Publication Date
HK1133991A1 true HK1133991A1 (en) 2010-04-16

Family

ID=39468571

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10102016.4A HK1133991A1 (en) 2006-10-12 2010-02-25 Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice

Country Status (6)

Country Link
US (9) US8791153B2 (fr)
EP (2) EP2653160B1 (fr)
CA (1) CA2666365C (fr)
ES (1) ES2653259T3 (fr)
HK (1) HK1133991A1 (fr)
WO (1) WO2008067054A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8791153B2 (en) 2006-10-12 2014-07-29 Sanofi-Topaz, Inc. Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
WO2008137699A2 (fr) * 2007-05-04 2008-11-13 Topaz Pharmaceuticals Llc Formulations topiques et procédés d'élimination et de prophylaxie de souches de poux susceptibles et résistantes au traitement avec de multiples modes d'action
BRPI0919150A2 (pt) 2008-09-23 2015-12-08 Larada Sciences Inc aplicadores de fluxo de ar e métodos de tratamento relacionados
JP5694944B2 (ja) * 2008-10-29 2015-04-01 トパズ ファーマシューティカルズ インコーポレイティド エマルション系局所治療用製剤の保存方式
TWI474841B (zh) * 2009-10-29 2015-03-01 Topaz Pharmaceuticals Inc 乳劑基治療局部製劑的保存系統
US20130252911A1 (en) 2009-11-02 2013-09-26 Alpha-Biocare Gmbh Compositions comprising flavonoid-containing extracts from plants of the genus citrus and/or isolated citrus flavonoids and specific cationic surface active agents, and said composition for use as an agent for treating infestations with head lice
US8174322B2 (en) 2010-05-04 2012-05-08 Nxp B.V. Power control of reconfigurable outphasing chireix amplifiers and methods
EP3326614A1 (fr) * 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprenant des composés d'avermectine sans solvants et agents pro-pénétrants de composés d'avermectine
EP3326609A1 (fr) * 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprenant des composés d'avermectine sans agents de gélification
EP3326608A1 (fr) 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprenant des composés d'avermectine sans matières grasses solides
EP4062907A1 (fr) 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US180352A (en) * 1876-07-25 Improvement in parlor shooting-galleries
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4444865A (en) * 1981-11-12 1984-04-24 Eastman Kodak Company Blended grain direct-positive emulsions and photographic elements and processes for their use
EP0179583A1 (fr) 1984-10-04 1986-04-30 Merck & Co. Inc. Système pour augmenter la vitesse de dissolution dans l'eau et la solubilité de médicaments peu solubles
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
ES2319699T3 (es) * 1996-05-20 2009-05-11 Otsuka Pharmaceutical Co., Ltd. Remedio para la rosacea.
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
EP0969790A2 (fr) * 1997-02-21 2000-01-12 Beiersdorf Aktiengesellschaft Compositions de traitement de l'acne rosacee
US6107397A (en) * 1997-03-24 2000-08-22 Basf Aktiengesellschaft Aqueous copolymer dispersions of water-soluble monomers with N-vinyl groups and hydrophobic monomers
US6006758A (en) * 1998-02-03 1999-12-28 University Of Maryland Method and device for the detection and removal of head lice
US20040166183A1 (en) * 1998-05-20 2004-08-26 Ruseler-Van Embden Johanna G. H. Methods and means for preventing or treating inflammation or pruritis
US6103248A (en) 1998-05-22 2000-08-15 Burkhart; Craig G. Topical preparation and therapy for head lice
AU750046B2 (en) 1998-07-02 2002-07-11 Elanco Us Inc. Formulations for controlling human lice
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6524602B1 (en) 1998-10-13 2003-02-25 Craig G. Burkhart Polymer delivery system in treatments for parasitic skin diseases
WO2000042990A1 (fr) * 1999-01-25 2000-07-27 Optime Therapeutics, Inc. Formulations de liposomes
US6265384B1 (en) * 1999-01-26 2001-07-24 Dale L. Pearlman Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents
US6262031B1 (en) 1999-03-12 2001-07-17 Merck & Co., Inc. Method for treating pediculosis capitisinfestation
US6927210B1 (en) 1999-08-12 2005-08-09 Eli Lilly And Company Ectoparasiticidal aqueous suspension formulations of spinosyns
EA004251B1 (ru) 1999-08-12 2004-02-26 Эли Лилли Энд Компани Эктопаразитицидные водные суспензионные препараты спинозинов
US20030180352A1 (en) 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
US6399651B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6319945B1 (en) 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6727228B2 (en) 2001-04-25 2004-04-27 Johnson & Johnson Consumer Companies, Inc. Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
US20030040504A1 (en) 2001-05-09 2003-02-27 Gans Eugene H. Ectoparasiticidal compositions and methods of their use
WO2003024223A1 (fr) 2001-09-17 2003-03-27 Eli Lilly And Company Preparations pesticides
US7064108B2 (en) 2002-02-08 2006-06-20 Merck & Co., Inc. Topical ivermectin composition
US20040097377A1 (en) 2002-03-21 2004-05-20 Hahn Donald R. Pesticidal spinosyn derivates
US6663876B2 (en) * 2002-04-29 2003-12-16 Piedmont Pharmaceuticals, Llc Methods and compositions for treating ectoparasite infestation
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
EP1620113B1 (fr) * 2003-04-24 2011-07-13 Galderma S.A. Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US6927206B2 (en) * 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
EP1663142A2 (fr) 2003-06-23 2006-06-07 MacroChem Corporation Compositions et procedes pour administration topique
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
US20050220742A1 (en) 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
PL1744763T3 (pl) 2004-04-29 2010-06-30 Elanco Us Inc Spinozyny do gojenia ran
DE102004025357B4 (de) * 2004-05-19 2007-03-29 Beiersdorf Ag Emulsionskonzentrat mit wasserlöslichen und öllöslichen Polymeren und kosmetische Zubereitung enthaltend Emulsionskonzentrat sowie ein Verfahren zu dessen Herstellung und dessen Verwendung
EP1609460A1 (fr) 2004-06-24 2005-12-28 The Procter & Gamble Company Compositions de soin pour la peau comprenant un corps gras ayant un domaine de fusion de 21-40 C
US8791153B2 (en) 2006-10-12 2014-07-29 Sanofi-Topaz, Inc. Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
WO2008137699A2 (fr) 2007-05-04 2008-11-13 Topaz Pharmaceuticals Llc Formulations topiques et procédés d'élimination et de prophylaxie de souches de poux susceptibles et résistantes au traitement avec de multiples modes d'action
JP5694944B2 (ja) 2008-10-29 2015-04-01 トパズ ファーマシューティカルズ インコーポレイティド エマルション系局所治療用製剤の保存方式

Also Published As

Publication number Publication date
CA2666365C (fr) 2016-08-09
ES2653259T3 (es) 2018-02-06
WO2008067054A2 (fr) 2008-06-05
EP2091325A4 (fr) 2010-12-15
US20180242584A1 (en) 2018-08-30
US20220095621A1 (en) 2022-03-31
US8791153B2 (en) 2014-07-29
EP2091325B1 (fr) 2014-08-06
US20170118985A1 (en) 2017-05-04
WO2008067054A3 (fr) 2008-12-18
US20110275582A1 (en) 2011-11-10
US20150105340A1 (en) 2015-04-16
US8927595B2 (en) 2015-01-06
US20080214657A1 (en) 2008-09-04
US20220159961A1 (en) 2022-05-26
EP2653160B1 (fr) 2017-09-27
US11229207B2 (en) 2022-01-25
EP2091325A2 (fr) 2009-08-26
US20200221700A1 (en) 2020-07-16
CA2666365A1 (fr) 2008-06-05
EP2653160A1 (fr) 2013-10-23
US20190166844A1 (en) 2019-06-06

Similar Documents

Publication Publication Date Title
HK1133991A1 (en) Shampoo conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment resistant strains of lice
IL269370B (en) Chemicals, preparations and methods for the treatment and prevention of orthopoxvirus infections and related diseases
IL250858A0 (en) Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
IL195142A (en) Processed arylaimidazolone and triazolone, their preparation process, pharmaceutical preparations containing them for the treatment or prevention of diseases
HK1134679A1 (zh) 用於治療感染的組合物和方法
WO2006013441A3 (fr) Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau
EP1868628A4 (fr) Composes, compositions et methodes de traitement des infections a poxvirus
EP2192901A4 (fr) Agents chimiques, compositions et procédés de traitement et de prévention des infections à orthopoxvirus et des maladies associées
HK1180237A1 (zh) 抗微生物肽,組合物和使用方法
GB0718446D0 (en) Compositions and methods for the treatment of infection
IL195272A0 (en) Methods and compositions for the treatment of viral infections
IL187111A0 (en) Use of tfpi to treat severe bacterial infections
ZA201101517B (en) Compositions for the prophylaxis and treatment of dermatological/mucosal diseases,and uses thereof
LT2111855T (lt) Antibakteriės kompozicijos, skirtos viršutinių ir apatinių kvėpavimo takų infekcijų gydymui
WO2008097364A3 (fr) Utilisation de l'oritavancine pour la prévention et le traitement de l'anthrax
IL210975A (en) Annapomapungin History, Pharmaceuticals Containing Them and Their Use in Preparing Medicines to Treat Fungal Infections
ZA200809686B (en) Lysobactin amindes
IL206104A (en) Aminazoles, pharmaceuticals containing them and their use in the preparation of bacterial infections
SI2134742T1 (sl) Imunogene zmesi za zdravljenje in prepreäśevanje ĺ˝ivalskih okuĺ˝b
EP2326340A4 (fr) Compositions et procédés destinés à traiter une infection par s. pneumoniae
WO2007070536A3 (fr) Agents antibacteriens 7-quinolyl cetolide
EP2328611A4 (fr) Compositions et procédés destinés à traiter une infection par s. pneumoniae
IL211283A0 (en) Compositions and use thereof for treating s. pneumoniae infection
IL211282A0 (en) Compositions and use thereof for treating s. pneumoniae infection